HTTP Interface and External Systems for Phase I Clinical Trial Pre-screening

Phase I clinical trial pre-screening data primarily originates from Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC) systems

Data Characteristics

Phase I clinical trial pre-screening data primarily originates from Clinical Trial Management Systems (CTMS), Electronic Data Capture (EDC) systems, Electronic Medical Record (EMR) systems, and some biobank systems. This data typically includes subject demographics, medical history, physical examination results, laboratory test data, imaging reports, and informed consent status. Data updates frequently occur during the trial, especially for laboratory results, which may update daily.

Data document structures are complex. They often follow CDISC (Clinical Data Interchange Standards Consortium) standards like SDTM (Study Data Tabulation Model) or ADaM (Analysis Data Model). These formats contain extensive structured and semi-structured data. Field names commonly use medical terminology, such as SubjectID, VisitDate, LabTestCode, ResultValue, and Unit. Units strictly adhere to international standards or common clinical units, for example, mmol/L, ng/mL, mmHg.

Constraints Imposed by Data Characteristics on "HTTP Interface and External Systems"

The highly structured nature and strict update frequency of Phase I clinical trial pre-screening data require HTTP interfaces to efficiently retrieve and parse data. Data sources are decentralized and diverse, necessitating interface designs that accommodate various authentication mechanisms, such as OAuth2.0 or API Keys. Data from EDC and EMR systems often have strict access controls and rate limits. Design request intervals carefully.

CDISC standard complexity demands robust pattern matching and field mapping capabilities during data parsing. This ensures data accuracy and completeness. Standardized unit handling is crucial. If interface-returned data has inconsistent units, convert them at the integration layer. Data volume is relatively small, but its sensitivity requires HTTPS for transmission and data encryption to comply with regulations like HIPAA.

Configuration Guidelines

Configuration ItemSuggested ValueRationale
API_KEYKey provided by the data source systemEnsures authentication and authorization for external systems, preventing unauthorized access
requestTimeout60 secondsAccommodates complex queries and potential network latency, ensuring data integrity
maxConnections50Balances external system load with data retrieval efficiency, preventing overload
dataParseModeJSONPath or XPathCDISC standard data is often in JSON or XML format, supporting precise field extraction
unitConversionMap{"mg/dL": "mmol/L", ...}Standardizes medical units from different data sources, ensuring data consistency
retryAttempts3Handles temporary network fluctuations or external system busyness, improving interface stability

Common Pitfalls

  • An HTTP 500 error with empty content from the interface typically indicates an internal logic error in the external system or incorrect data query parameters.
  • An empty ResultValue field or missing Unit field for laboratory test results often results from incomplete adherence to external system API documentation or incorrect JSONPath / XPath expressions.
  • Automatic shutdown of the large model service configured in OneAPI can occur due to an expired external API key, depleted quota, or OneAPI's health check failure for specific model interfaces.

Verification Steps

  • Use FastGPT's interface debugging tool. Call the interface with a preset Phase I clinical subject ID. Check if core fields like SubjectID, VisitDate, and LabTestCode in the returned data are accurate.
  • Examine key laboratory test results, such as complete blood count, liver, and kidney function indicators. Verify the ResultValue and Unit fields. Confirm that values and units match the original data source, paying close attention to whether units have been correctly converted according to unitConversionMap.
  • Simulate concurrent requests. Observe interface response times and success rates. Ensure the interface remains stable and provides data during peak Phase I clinical trial data update periods.

The values given are common starting points and should be measured against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.